Corvus Pharmaceuticals, Inc.
🏢 View company profile →15Patents
15Active
15Granted
48Portfolio score
Filing activity: Dec 9, 2016 → Apr 7, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10870652B2 | Compounds and methods for modulating bruton's tyrosine kinase | Chemistry; Metallurgy | 2 | Active |
| US10822426B2 | Humanized anti-CD73 antibodies | Physics | 2 | Active |
| US11008314B2 | Compounds and methods for modulating interleukin-2-inducible t-cell kinase | Chemistry; Metallurgy | 1 | Active |
| US11266649B2 | Pharmaceutical formulations | Human Necessities | 1 | Active |
| US10912776B2 | Methods of treating cancer | Chemistry; Metallurgy | 1 | Active |
| US11040040B2 | Methods of treating cancer | Chemistry; Metallurgy | 1 | Active |
| US12023337B2 | Methods of treating cancer | Chemistry; Metallurgy | 0 | Active |
| US12174192B2 | Methods for detecting and treating cancers having adenosine pathway activation | Physics | 0 | Active |
| US10654825B2 | Processes for making triazolo[4,5D] pyramidine derivatives and intermediates thereof | Chemistry; Metallurgy | 0 | Active |
| US11254686B1 | Compounds and methods for modulating adenosine A2B receptor and adenosine A2A receptor | Chemistry; Metallurgy | 0 | Active |
| US10793636B2 | Anti-CD73 antibodies | Chemistry; Metallurgy | 0 | Active |
| US11859007B2 | Humanized anti-CD73 antibodies | Physics | 0 | Active |
| US11897874B2 | Compounds and methods for modulating Interleukin-2-inducible T-cell kinase | Chemistry; Metallurgy | 0 | Active |
| US12351644B2 | Anti-CD73 antibodies | Chemistry; Metallurgy | 0 | Active |
| US12116635B2 | Methods for detecting and treating cancers having adenosine pathway activation | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.